About 250 healthcare professionals, including leaders in the field of nephrology, gathered at the Second Qatar Nephrology Conference hosted by Hamad Medical Corporation (HMC) with QNB as the main sponsor.
Currently, there are about 80 patients on the waiting list, and 300 patients are under work-up, for kidney transplantation in
Qatar.
The conference featured experts from all over the world who discussed the latest research and other developments in different aspects of renal and transplantation medicine. The event featured 15 international speakers.
“The incidence and prevalence of renal diseases are on the rise all over the world, and fighting them is a major health challenge for the future. Chronic diseases such as diabetes and hypertension still represent the major causes of end-stage renal disease – a kidney failure so advanced that it cannot be reversed or treated with conventional medical treatments,” said Dr Hassan al-Malki, head, nephrology
department, HMC.
“This conference is part of HMC’s efforts to build capacity in Qatar and the region for the delivery of high quality preventive and therapeutic healthcare, which is a priority of Qatar’s National
Health Strategy,” said Dr al-Malki.
According to QNB’s Group communications team, the sponsorship of the conference is part of the group’s efforts to support the development of healthcare and medicine in Qatar, and part of QNB’s extensive corporate social responsibility programme.
The conference builds upon the success of the first Qatar Nephrology Conference held in 2013. It aimed to provide healthcare professionals in the region an opportunity to share their knowledge and expertise, and foster collaborations with international centres that can contribute to the development of HMC’s transplantation and dialysis programmes.